Our MR analysis identified nine CLL-associated proteins, seven (CD177, SIGLEC5, MDGA2, LILRA1, HLA-C, MICA, PPIE) significantly increased CLL risk, while POGNT2 and CCL14 were associated with reduced risk. Here, SIGLEC5 is linked to B-cell chronic lymphocytic leukemia.